Tilray Inc.: “Tilray’s OK. Big short squeeze. We’ve got two that we like: our favorite is Canopy [Growth]. That’s because they’ve got the $4 bil[lion] from Constellation. And our second one is going to be Cronos [Group]. And we’re going to stick with our two. Those are the ones that brought us here.”
Fitbit Inc.: “I would’ve liked Fitbit at one time like I would’ve liked Fossil. I know, obviously, Fitbit is better in terms of health, but the Apple Watch is king. And while Fitbit can sneak back, you know: own Apple, don’t trade it.”
Moderna Inc.: “I pulled up with these guys when I was at the J.P. Morgan Healthcare Conference and I was quite impressed. I think it is a winner. Now, a little speculative, but you’ve got a good call.”
Exelixis Inc.: “We like Exelixis. We think that it’s got a lot of good stuff, but we realize that it is speculative. We profiled it several times and we’re on board.”
Maxar Technologies Inc.: “No, no, no. Way too speculative. I don’t know why it will bounce. I’m going to have to say don’t buy.”
International Paper Co.: “I wish that they really were a play on paper straws. I made the same mistake with Westrock. They’re really a play on worldwide growth and there isn’t enough worldwide growth right now, so we’re going to stay away from IP.”
Disclosure: Cramer’s charitable trust owns shares of Apple and J.P. Morgan.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Questions, comments, suggestions for the “Mad Money” website? firstname.lastname@example.org